id,filing_uuid,filing_type,registrant_name,registrant_id,client_name,filing_year,filing_period,issue_code,specific_issues,government_entities,income_amount,expense_amount,is_no_activity,is_termination,received_date
1291645,f6be8340-5748-4a98-935d-99425113ff0b,Q3,PRIME THERAPEUTICS,400339576,PRIME THERAPEUTICS,2012,third_quarter,PHA,"Specialty pharmacy facility opening
H.R. 4215: Medicare Pharmacy Transparency and Fair Auditing Act
H.R. 1971: Pharmacy Competition and Consumer Choice Act of 2011
S. 1058: Pharmacy Competition and Consumer Choice Act of 2011","HOUSE OF REPRESENTATIVES,SENATE",,170000,0,0,2012-07-24T15:11:47.357000-04:00
1294140,24c329ad-00da-43d9-8eb4-c8b9777c97d6,3T,AMYLIN PHARMACEUTICALS,308536,AMYLIN PHARMACEUTICALS,2012,third_quarter,PHA,"Perscription Drug User Fee Act Reauthorization
FDA funding and agency effectiveness
Drug importation issues
Safeguarding America's Pharmaceuticals Act of 2011- H.R. 3026","HOUSE OF REPRESENTATIVES,SENATE",,170000,0,1,2012-09-19T14:47:16.540000-04:00
1294748,93479c6f-5b6d-473d-b769-f8e86345d6b7,Q3,"CYBER SECURITY RESEARCH CONSULTANTS, LLC",91694,PDFRAZER CONSULTING INC CANADIAN INTERNATIONAL PHARMACY ASSOCIATION,2012,third_quarter,PHA,"Food and Drug Safety Globalization Act
Monitoring Dorgan-Snowe Drug reimportation from Canada
Monitoring FDA Reauthorization Act","HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2012-10-01T11:38:38.777000-04:00
1295089,1adcf7e2-fbc5-4d46-8368-a7135db2065a,Q3,LONG TERM CARE PHARMACY ALLIANCE,400309443,LONG TERM CARE PHARMACY ALLIANCE,2012,third_quarter,PHA,Medicare Part D,"Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE",,201000,0,0,2012-10-03T09:35:23.533000-04:00
1295147,8ee1d045-b7b2-479a-a8a7-ec8038ded7c7,Q3,AMERICAN COLLEGE OF CLINICAL PHARMACY,57258,AMERICAN COLLEGE OF CLINICAL PHARMACY,2012,third_quarter,PHA,Coverage for direct patient care services of qualified pharmacists under Medicare and other public health programs.,"Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE",,61700,0,0,2012-10-03T11:38:48.013000-04:00
1295391,a67913ed-5ef6-456e-819d-2467c0d5d390,Q3,GRIZZLE COMPANY,16987,KENTUCKYONE HEALTH (FORMERLY JEWISH HOSPITAL HEALTH CARE SERVICES),2012,third_quarter,PHA,"S.3187, The Food and Drug Administration Safety and Innovation Act (FDASIA): Support provision to give FDA enhanced authority to address drug shortages.
Proposed changes to the 340B hospital drug program.","HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2012-10-04T14:04:12.270000-04:00
1295546,3f79de6a-bc6a-4cc4-83d6-6dab786f391c,Q3,"PARRY, ROMANI, DECONCINI & SYMMS",30792,"BRAIDWOOD MANAGEMENT, INC.",2012,third_quarter,PHA,"Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens.  No specific legislation has been introduced yet.
Legislation affecting the operation of compounding pharmacies and the availability of compounded medications.   No specific legislation has been introduced yet.","HOUSE OF REPRESENTATIVES,SENATE",11250,,0,0,2012-10-05T13:14:14.943000-04:00
1295553,43599881-3884-4449-af27-3a30a6df1b57,Q3,"SHELTER ROCK STRATEGIES, LLC",400772326,NEW YORK MEDICAL COLLEGE,2012,third_quarter,PHA,"BARDA Solicitation HHS 11-100SOL-00011, Centers for Innovation in Advanced Development and Manufacturing, Assess the likelihood this solicitation will get funded, assess competition, assist in writing and getting signed memoranda of support from the NY Congressional Delegation, and assist in obtaining support from NY State to aide the client's proposal.",,,,0,0,2012-10-05T13:20:16.437000-04:00
1295558,88c9c96b-fbd1-48d7-933a-152ef81527bd,Q3,"PARRY, ROMANI, DECONCINI & SYMMS",30792,DIAMONDBACK DRUGS,2012,third_quarter,PHA,"Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens.   No specific legislation has been introduced yet.
Legislation affecting the operation of compounding pharmacies and the availability of compounded medications.  No specific legislation has been introduced yet.","HOUSE OF REPRESENTATIVES,SENATE",6000,,0,0,2012-10-05T13:35:19.340000-04:00
1295579,508810e1-0f7b-494c-afef-7241dc4e60f0,Q3,"PARRY, ROMANI, DECONCINI & SYMMS",30792,"VETERINARY PHARMACIES OF AMERICA, INC.",2012,third_quarter,PHA,"Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens.  No specific legislation introduced yet.
Legislation affecting the operation of compounding pharmacies and the availability of compounded medications.  No specific legislation introduced yet.","HOUSE OF REPRESENTATIVES,SENATE",11250,,0,0,2012-10-05T14:39:33.297000-04:00
1295590,2f46c21f-df05-402f-b105-0ba48de4a478,Q3,"PARRY, ROMANI, DECONCINI & SYMMS",30792,"WEDGEWOOD VILLAGE PHARMACY, INC.",2012,third_quarter,PHA,"Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens.   No specific legislation introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications.  No specific legislation has been introduced yet.

Regulatory issues involving compounded 17P and compounded Avastin.","HOUSE OF REPRESENTATIVES,SENATE",11250,,0,0,2012-10-05T14:45:38.743000-04:00
1295604,1488395d-1238-473b-9275-c49f2224b83a,Q3,"PARRY, ROMANI, DECONCINI & SYMMS",30792,"WOMEN'S INTERNATIONAL PHARMACY, INC.",2012,third_quarter,PHA,"Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens.  No specific legislation introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications.  No specific legislation introduced yet.

Regulatory issues involving compounded 17P.","HOUSE OF REPRESENTATIVES,SENATE",11250,,0,0,2012-10-05T14:53:44.530000-04:00
1295659,93fc65cc-c81a-44f3-b39e-e623a5bc7a62,Q3,AMERICAN AMBULANCE ASSOCIATION,56018,AMERICAN AMBULANCE ASSOCIATION,2012,third_quarter,PHA,Supported efforts to address the drug shortage issue in the Food and Drug Administration Safety and Innovation Act (S. 3187) as it pertains to emergency medical service providers.,"Centers For Medicare and Medicaid Services (CMS),Government Accountability Office (GAO),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Medicare Payment Advisory Commission (MedPAC),SENATE,Veterans Affairs, Dept of (VA)",,295000,0,0,2012-10-06T19:56:19.673000-04:00
1295731,8598c359-ca70-4cac-9da3-4c906139fc9a,Q3,UNIVERSITY OF IOWA,49191,UNIVERSITY OF IOWA,2012,third_quarter,PHA,"Increased appropriations for systems to shorten the time between development of a drug and its release to the public
FDA reform as it relates to drug development and research         FDA User Fee Bill
Collaborative research on drug development                                 anti-malarial pharmaceuticals
FY 2011 Agricultural Appropriations                                             human factors research related to neuropharmaceuticals","Agriculture, Dept of (USDA),Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Federal Emergency Management Agency (FEMA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,State, Dept of (DOS),Transportation, Dept of (DOT)",,88684,0,0,2012-10-08T10:26:43.090000-04:00
1295815,8af6d82a-414a-462e-aad9-90e8d8781687,Q3,HOLLAND & KNIGHT LLP,18466,"SAFECOR HEALTH, LLC",2012,third_quarter,PHA,"Drug supply chain provisions in federal legislation; specifically S.3187, The Food & Drug Administration Safety & Innovation Act and H.R. 5651, The Food & Drug Administration Reform Act of 2012. Advocated for provisions recognizing the role of drug repackagers and against provisions to make certain hydrocodone products schedule 2 controlled substances.","HOUSE OF REPRESENTATIVES,SENATE",10000,,0,0,2012-10-08T14:03:35.477000-04:00
1295914,7da1c3b9-ce9d-4a84-a61d-d0dbeb7b6ff0,Q3,INJURED WORKERS PHARMACY,400765309,INJURED WORKERS PHARMACY,2012,third_quarter,PHA,Transparency of Pharmacy Benefit Managers (bill sponsored by Rep. McMorris-Rodgers and Senator Mark Pryor); Longshoreman and Harbor Workers Amendment Act of 2011 sponsored by Senator Isakson.,"HOUSE OF REPRESENTATIVES,SENATE",,,0,0,2012-10-09T09:34:38.413000-04:00
1296148,0bc1dd46-4989-4d05-b8c1-75f794f0c933,Q3,"PARRY, ROMANI, DECONCINI & SYMMS",30792,"POZEN, INC.",2012,third_quarter,PHA,To provide incentives for new drug development.  No specific bills pending.,"HOUSE OF REPRESENTATIVES,SENATE",36000,,0,0,2012-10-09T15:52:28.043000-04:00
1296213,48be7002-207e-4a0e-a8ce-68a264776bba,Q3,GREATER NEW YORK HOSPITAL ASSOCIATION,16830,GREATER NEW YORK HOSPITAL ASSOCIATION,2012,third_quarter,PHA,"Reducing the costs of pharmaceuticals, medical devices, and supplies for consumers and health care providers, including drug shortage legislation (S. 296, H.R. 2245), potential drug shortage legislation, potential price gouging legislation, medical device pricing issues, and preserving access to group purchasing organizations; The Food and Drug Administration Safety and Innovation Act (S.3187); issues related to unique device identification.","Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office",,210000,0,0,2012-10-10T09:52:07.243000-04:00
1296399,b0ffd845-45b6-4f54-afd9-0f040a1f2eac,Q3,INDEPENDENT PHARMACY COOPERATIVE,313098,INDEPENDENT PHARMACY COOPERATIVE,2012,third_quarter,PHA,"CMS Average Manufacturer Price (AMP) Final Rule. Reporting by manufacturers and calculation.
Potential prescription drug track-and-trace legislation. RxTEC
National Average Drug Acuisition Cost (NADAC) implementation. Calculation and Process 
National Average Retail Price (NARP) implementation.","Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE",,10000,0,0,2012-10-10T12:36:26.380000-04:00
1296683,2d700ed6-38b0-4ec6-bf77-76bdef84a7d0,Q3,CAPITOL HILL CONSULTING GROUP,72053,PURDUE PHARMA LLP,2012,third_quarter,PHA,"Controlled Drug Substances Act (21 USC 13)
Stop Oxy Abuse Act (H.R. 1316)","HOUSE OF REPRESENTATIVES,SENATE",15750,,0,0,2012-10-10T16:37:33.080000-04:00
1296774,33c49f5f-27bf-4cf8-80cf-c23064b2f221,Q3,"GREENBERG TRAURIG, LLP",16896,NATIONAL COMMUNITY PHARMACISTS ASSOCIATION (NCPA),2012,third_quarter,PHA,Health care legislative and regulatory issues affecting independent community pharmacies.,"Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB)",30000,,0,0,2012-10-11T08:52:21.290000-04:00
1297166,a6e139c3-c408-4743-9cbc-7ef41a846515,Q3,RED+BLUE STRATEGIES,400693064,EXPRESS SCRIPTS INC.,2012,third_quarter,PHA,"H.R. 1946 - Preserving Our Hometown Independent Pharmacies Act of 2011, which creates and antitrust exemption for certain pharmacies.

Rules, regulations and guidance specific to prescription drug pricing, generic utilization and specialty pharmacy. Issues impacting PBMs included in the Prescription Drug User Fee Act reauthorization and the Generic Drug User Fee Reauthorization.

Policies related to stopping the diversion of prescription medications in the nation's drug supply chain.","Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",60000,,0,0,2012-10-11T15:34:00.973000-04:00
1297234,af3cfece-449d-4071-b071-21b43f9e88a8,Q3,"MERCURY PUBLIC AFFAIRS, LLC",70175,EXPRESS SCRIPTS INC.,2012,third_quarter,PHA,Prescription drug monitoring.,"HOUSE OF REPRESENTATIVES,SENATE",40000,,0,0,2012-10-11T16:34:29.043000-04:00
1297251,be6042cb-af8c-466f-8323-dfbd5cbbb252,Q3,ATRIUM HEALTH-FORMERLY KNOWN AS CAROLINAS HEALTHCARE SYSTEM,58534,ATRIUM HEALTH - FORMERLY KNOWN AS CAROLINAS HEALTHCARE SYSTEM,2012,third_quarter,PHA,"H.R. 2674
Supportive of any language that amends section 340B of the Public Health Service Act to revise and expand the drug discount program under that section to improve the provision of discounts on drug purchases for certain safety net providers by expanding 340B discounts to impatient settings.","HOUSE OF REPRESENTATIVES,SENATE",,114550,0,0,2012-10-11T17:00:39.870000-04:00
1297308,933f9084-40f0-43b0-9963-e2b884207c95,Q3,"DUTKO WORLDWIDE, LLC",12868,NEWAYS INTERNATIONAL,2012,third_quarter,PHA,"Monitor legislation pertaining to dietary supplements and pharmaceuticals, particularly the Food Safety Modernization Act (PL 111-353) and Patient Protection and Affordable Care Act (PL 111-148).","Executive Office of the President (EOP),HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2012-10-11T17:27:00.150000-04:00
1297555,a4ba8e66-7862-47b2-886a-90c722469452,3T,STEVE BUYER GROUP,400701097,OMNICARE,2012,third_quarter,PHA,Advocacy in support of S.1560 promoting changes to the Controlled Substance Act providing access to pain medication for nursing.,,30000,,0,1,2012-10-12T11:09:45.590000-04:00
1297826,93340bfd-9ef9-4259-a090-915515e0b886,Q3,"RYAN MACKINNON VASAPOLI AND BERZOK, LLP",30187,NOVO NORDISK,2012,third_quarter,PHA,"P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010: Issues regarding comparative effectiveness, implementation of Physician Payment Sunshine provisions and Prescription Drug Sample transparency reporting provisions; S.3187 FDA Safety and Innovation Act (PDUFA V); H.R. 4274 Best Pharmaceuticals for Children Act/Pediatric Research Exclusivity Act; H.R. 3026 Safeguarding America's Pharmaceuticals Act of 2011; Pharmaceutical Traceability Enhancement Code (Rx TEC) Act; H.R. 5973 FY2013 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act (FDA funding); 340B","Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Executive Office of the President (EOP),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Labor, Dept of (DOL),Natl Institutes of Health (NIH),SENATE",30000,,0,0,2012-10-12T14:16:17.543000-04:00
1297833,1e7cedf7-292f-454e-a82f-1d6de6676cf7,Q3,"RYAN MACKINNON VASAPOLI AND BERZOK, LLP",30187,GENENTECH,2012,third_quarter,PHA,Monitor Drug Safety and pedigree legislation. Monitor legislation and oversight on compounding pharmacies.,"Executive Office of the President (EOP),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",60000,,0,0,2012-10-12T14:22:21.160000-04:00
1298211,9d991209-6ba2-4a4f-bfcb-dc6947cca800,Q3,"HEARTLAND SOLUTIONS GROUP, INC.",312133,ZEBRA TECHNOLOGIES CORPORATION,2012,third_quarter,PHA,"Any and all issues related to barcode, secure identification and real-time location systems.","HOUSE OF REPRESENTATIVES,SENATE",41250,,0,0,2012-10-14T12:21:29.757000-04:00
1298709,eda75f89-94c5-4e02-8594-2349159f58b8,Q3,AMERICAN ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS,1672,AMERICAN ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS,2012,third_quarter,PHA,"the Prescription Drug Abuse Prevention and Treatment Act of 2011 (S. 507/H.R. 1925)
the Stop Oxy Abuse Act of 2011 (H.R. 1316)
the Ryan Creedon Act of 2011 (H.R. 2119)
Prescription Drug User Fee Act (PDUFA) reauthorization legislation (H.R. 5651/S. 3187)","Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Natl Drug Control Policy (NDCP),SENATE",,24599,0,0,2012-10-15T11:55:22.777000-04:00
1299014,d15869e2-bfcd-4dfa-8a89-eab28aa0fa78,Q3,DENNY MILLER ASSOCIATES,25328,CELL THERAPEUTICS,2012,third_quarter,PHA,European Union approval of US cancer drugs.,"HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2012-10-15T13:55:42.557000-04:00
1299361,9039e44d-58d9-4edd-a18d-a60f791fce72,Q3,UPS (UNITED PARCEL SERVICE),39223,UPS (UNITED PARCEL SERVICE),2012,third_quarter,PHA,- HR 2405 / S.1855 Healthcare Supply Chain Safety - track and trace in the Prescription Drug Users Fee Act,"Energy, Dept of,Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Labor, Dept of (DOL),Postal Regulatory Commission,SENATE,State, Dept of (DOS),Transportation, Dept of (DOT),Transportation Security Administration (TSA),Treasury, Dept of,U.S. Customs & Border Protection,U.S. Trade Representative (USTR),White House Office",,961174,0,0,2012-10-15T15:33:05.367000-04:00
1300423,7c12ea80-3ea4-45dc-849c-89963c9e7aab,Q3,NATIONAL COMMUNITY PHARMACISTS ASSOCIATION,27478,NATIONAL COMMUNITY PHARMACISTS ASSOCIATION,2012,third_quarter,PHA,"S. 1058 and H.R. 1971, the Pharmacy Competition and Consumer Choice Act of 2011; H.R. 1936, the Medicare Access to Diabetes Act of 2011; H.R. 1946, the Preserving Our Hometown Independent Pharmacies Act of 2011; S. 1560, Nursing Home Resident Pain Relief Act of 2011; S. 1699, a bill to reduce the costs of prescription drugs under the Medicare program; SEE ADDENDUM S. 296, Preserving Access to Life-Savings Medications Act; Drug Cost Reduction Act; S. 2002 and H.R. 4095, Online Pharmacy Safety Act; S. 1251, Medicare and Medicaid FAST Act; S. 882, STOP Act; S. 319, Pharmaceutical Market Access and Drug Safety Act of 2011; S. 1002, SAFE Doses Act; H.R. 4215, The Medicare Pharmacy Transparency and Fair Auditing Act; Prescription Drug User Fee Act; Pharmaceutical Supply Chain Security; Drug Shortages legislation; Prescription drug diversion and abuse; TRICARE Pharmacy Benefit/Provisions for inclusion in National Defense Authorization Act for FY2013; Medicare Part B Revalidation; Hydrocodone Issues; S. 3376, PACT Act, S. 2467 and S. 3254 and H.R. 4310, the National Defense Authorization Act for Fiscal Year 2013; S. 3604, Improving Dementia Care Treatment for Older Adults Act of 2012;","Agency for Healthcare Research & Quality (AHRQ),Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Drug Enforcement Administration (DEA),Food & Drug Administration (FDA),Government Accountability Office (GAO),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),Office of Personnel Management (OPM),SENATE",,300000,0,0,2012-10-16T12:26:47.030000-04:00
1300438,de4b9fbb-3d03-4867-8a33-6baa9f22ee76,Q3,NOVO NORDISK INC.,284790,NOVO NORDISK INC.,2012,third_quarter,PHA,"P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010: Issues regarding comparative effectiveness, implementation of Physician Payment Sunshine provisions and Prescription Drug Sample reporting provisions;  S.3187 FDA Safety and Innovation Act; H.R. 4274 Best Pharmaceuticals for Children Act/Pediatric Research Exclusivity Act; H.R. 3026 Safeguarding America's Pharmaceuticals Act of 2011; Pharmaceutical Traceability Enhancement Code (Rx TEC) Act; H.R. 5973 FY2013 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act (FDA funding); 340B","Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Executive Office of the President (EOP),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Labor, Dept of (DOL),Natl Institutes of Health (NIH),SENATE,White House Office",,400000,0,0,2012-10-16T12:29:52.450000-04:00
1300856,4e7e92c9-a03e-4d7f-9edc-2ba6d20d7a14,Q3,"TAKEDA PHARMACEUTICALS AMERICA, INC.",57954,TAKEDA PHARMACEUTICALS AMERICA INC,2012,third_quarter,PHA,PDUFA,"Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",,280000,0,0,2012-10-16T14:32:54.040000-04:00
1301113,703be236-3d80-49bf-8687-bd5469cd590c,Q3,VENABLE LLP,39941,ENDO PHARMACEUTICALS INC,2012,third_quarter,PHA,"General issues affecting the pharmaceutical industry and bioequivelence.  (Generic pharmaceutical user fee act; H.R. 5651.)
The Life Sciences Jobs and Investment Act (S. 1410; H.R. 2632)","HOUSE OF REPRESENTATIVES,SENATE",50000,,0,0,2012-10-16T15:20:27.077000-04:00
1301301,52dbd21c-44a8-420d-bac2-ceeddf5f3001,Q3,"RYAN MACKINNON VASAPOLI AND BERZOK, LLP",30187,AMERISOURCEBERGEN CORPORATION,2012,third_quarter,PHA,Issues pertaining to Federal Drug Pedigree and Drug Shortages.,"HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2012-10-16T16:21:58.423000-04:00
1301375,e2b6f864-7224-4f12-94a3-07ca9c50092f,Q3,FOOD MARKETPLACE INC.,15097,FOOD MARKETPLACE INC,2012,third_quarter,PHA,"H.R. 1406 - Fairness to Pet Owners Act of 2011
S. 3376 - Preventing Abuse of Cough Treatments Act","Agriculture, Dept of (USDA),Executive Office of the President (EOP),Federal Reserve System,Federal Trade Commission (FTC),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Internal Revenue Service (IRS),Labor, Dept of (DOL),Office of Management & Budget (OMB),SENATE,Small Business Administration (SBA),Treasury, Dept of,White House Office",,180000,0,0,2012-10-16T16:39:39.347000-04:00
1301441,612fe9b3-409e-48cf-80f1-f00ffe84cf14,Q3,AMERICAN ACADEMY OF FAMILY PHYSICIANS,1342,AMERICAN ACADEMY OF FAMILY PHYSICIANS,2012,third_quarter,PHA,"No Bill Number, Proposal to create ""Special medical use"" category of prescription drugs, Should FDA create category of drugs that non physicians like pharmacists could prescribe.
No Bill Number, National Priorities and Research Agenda, PCORI should focus research on more common medical conditions first. No Bill, National Drug Control Strategy announcement, New CME for prescribers of opioid analgesics, Support drug control policies which are not burdensome to family physicians.","Agriculture, Dept of (USDA),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Medicare Payment Advisory Commission (MedPAC),Office of Management & Budget (OMB),SENATE,White House Office",,449038,0,0,2012-10-16T16:53:55.267000-04:00
1301823,753afa1c-b323-46f5-86a5-2a520b466de9,Q3,WINSTON & STRAWN LLP,41682,FRESENIUS KABI USA (FORMERLY KNOWN AS APP PHARMACEUTICALS INC ),2012,third_quarter,PHA,"Represent the client on issues related to assuring a safe, reliable supply of heparin and also on patent matters, including settlements and extensions.","HOUSE OF REPRESENTATIVES,SENATE",,,0,0,2012-10-17T09:36:15.990000-04:00
1301900,9e8fa94b-15ba-4b46-86fb-4360cc8561ab,Q3,BROWN RUDNICK LLP,287895,HEALTHCARE DISTRIBUTION ALLIANCE F/K/A HEALTHCARE DISTRIBUTION MANAGEMENT ASSOC,2012,third_quarter,PHA,H.R. 3026 Safeguarding America's Pharmaceuticals Act of 2011; H.R. 1065 & S. 1760- Pill Mill Crackdown Act of 2011; S.2997 relating to hydrocodone rescheduling.,"HOUSE OF REPRESENTATIVES,SENATE",50000,,0,0,2012-10-17T09:56:50.247000-04:00
1301914,94797f4f-bbca-4904-853e-eadfda1189ae,Q3,WINSTON & STRAWN LLP,41682,WOCKHARDT USA LLC,2012,third_quarter,PHA,Generic drug issues - federal preemption of state claims; FTC regulation of settlement agreements,"HOUSE OF REPRESENTATIVES,SENATE",,,0,0,2012-10-17T09:59:55.960000-04:00
1302196,0e83a118-fdb8-4e94-ab65-81ceadc3fb9e,Q3,"CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.",8511,AMERICAN SOCIETY OF HEMATOLOGY,2012,third_quarter,PHA,"Issues related to drug shortages. S.296/HR2245 Preserving Access to Life Saving Medications Act, HR3839 Drug Shortage Prevention Act; S.3187, FDA Safety and Innovation Act.","Centers For Disease Control & Prevention (CDC),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE",30000,,0,0,2012-10-17T10:58:36.760000-04:00
1302354,9826787a-01c4-45a6-8d0a-4c21db3db811,Q3,"CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.",8511,THE HEMOPHILIA ALLIANCE,2012,third_quarter,PHA,Issues realted to the 340B drug discount program.,"Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2012-10-17T11:18:52.393000-04:00
1302376,ab2e1f31-3f6e-4696-aeb6-439da1f6335d,Q3,FORGE FEDERAL AFFAIRS LLC,400865535,LILLY USA LLC,2012,third_quarter,PHA,Issues related to Prescription Drug User Fee Act (PDUFA).,"HOUSE OF REPRESENTATIVES,SENATE",10000,,0,0,2012-10-17T11:20:59.047000-04:00
1302383,620202c3-0809-4fa2-a6e8-df1432ae2eb1,Q3,"CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.",8511,NATIONAL HEMOPHILIA FOUNDATION,2012,third_quarter,PHA,"Issues related to hemophilia treatments, specialty pharmacies and the 340B drug purchasing program. S.3187, FDA Safety and Innovation Act.","Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE",50000,,0,0,2012-10-17T11:22:02.093000-04:00
1302400,b1a800cb-ab48-498b-b1c5-0188d6d5a1f3,Q3,"CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.",8511,NATIONAL ASSOCIATION OF EPILEPSY CENTERS,2012,third_quarter,PHA,Issues related to anti-epileptic drugs.,"Agency for Healthcare Research & Quality (AHRQ),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE",10000,,0,0,2012-10-17T11:24:10.340000-04:00
1302732,7e46d3d1-f8d9-4626-b1b9-af9751531f2c,Q3,OCHSNER CLINIC FOUNDATION,45391,OCHSNER CLINIC FOUNDATION,2012,third_quarter,PHA,"S. 296 A bill to amend the Federal Food, Drug, and Cosmetic Act to provide the Food and Drug Administration with improved capacity to prevent drug shortages.  All Provisions.","Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE",,160000,0,0,2012-10-17T12:33:29.197000-04:00
1303165,5664dc79-3633-4e4e-8014-d3a3db1d465e,Q3,"NORTH SOUTH GOVERNMENT STRATEGIES, FKA JDM PUBLIC STRATEGIES, LLC",400689052,TEVA PHARMACUETICALS USA,2012,third_quarter,PHA,PDUFA re-authorization; NDA-ANDA settlements,"HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2012-10-17T14:11:18.423000-04:00
1303245,84dcda17-6a39-468a-9fdf-60ba75ae0195,Q3,"NORTH SOUTH GOVERNMENT STRATEGIES, FKA JDM PUBLIC STRATEGIES, LLC",400689052,WOCKHARDT USA LLC,2012,third_quarter,PHA,PDUFA re-authorization; preemption for generic labeling,"HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2012-10-17T14:23:53.613000-04:00
1303393,1600de5e-e704-4d92-8701-a9c91a6d3ede,Q3,MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP),24486,"ALLIED  MEDICAL SUPPLY,  INC.",2012,third_quarter,PHA,Issues affecting resellers of pharmaceutical products,"HOUSE OF REPRESENTATIVES,SENATE",40000,,0,0,2012-10-17T14:36:53.563000-04:00
1303654,9dd8749d-9dd5-4846-a7e7-8c882d0a3fc0,Q3,RED+BLUE STRATEGIES,400693064,PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA),2012,third_quarter,PHA,"H.R. 1946 - Preserving Our Hometown Independent Pharmacies Act of 2011, which allows for an antitrust exception for certain pharmacies.

Issues related to the practice of giving coupons for certain prescription medications. S. 3187 - FDA Safety and Innovation Act - Issues related to supply chain safety, treatment of controlled substances and REMS policies.","Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE",60000,,0,0,2012-10-17T15:04:34.453000-04:00
1303672,f5074845-4add-4100-87d2-25fda3cfaaa5,Q3,RED+BLUE STRATEGIES,400693064,PEW CHARITABLE TRUSTS,2012,third_quarter,PHA,"H.R. 2182/S. 1734 - Generating Antibiotic Incentives Now Act .  Supporting work to increase innovation and development of new antibiotics.
S. 1584 - Drug Safety and Accountability Act- Supporting legislation and related Congressional activity regarding upstream supply stream safety. H.R. 3026- Safeguarding America's Pharmaceuticals Act. Supporting legislation and congressional activity regarding downstream supply chain safety.

S. 3187 - The FDA Safety and Innovation Act- specific work on antibiotic innovation, up and down stream supply chain issues, and medical device policies.

Policies related to the growing concerns regarding drug shortage issues in hospitals across the country.

Potential language related to Track and Trace provisions regarding downstream supply chain safety being considered by the Senate HELP and House Energy and Commerce Committees.","Centers For Medicare and Medicaid Services (CMS),Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2012-10-17T15:08:41.387000-04:00
1303841,d9e779fb-b1d1-431f-8a6e-49e34cf0cbb4,Q3,"WHITMER & WORRALL, LLC",292892,PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA),2012,third_quarter,PHA,Issues related to monitoring healthcare reform.,"Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2012-10-17T15:27:39.910000-04:00
1304030,481a29c1-d9e6-4b1b-80f7-c9ad98cf7a9c,Q3,MCDERMOTT WILL & SCHULTE LLP,24338,"ALLERGAN, INC.",2012,third_quarter,PHA,Issues related to Section 340B of the Public Health Service Act; FDA issues; health reform implementation,"Executive Office of the President (EOP),HOUSE OF REPRESENTATIVES,SENATE",10000,,0,0,2012-10-17T15:53:08.413000-04:00
1304291,5e4e875c-999a-4d4e-b178-7ef29a1063d8,Q3,AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS,3457,AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS,2012,third_quarter,PHA,"S. 3187, Support for the Drug Shortages provisions within the ""Food and Drug Administration Safety and Innovation Act."" H.R. 6413, support for the ""Transitional Care Act of 2012."" Contact concerning Food and Drug Administration (FDA) authority to manage drug shortages. Communications to FDA on approval of biosimilars and drug safety. Communications to Health Resources and Services Administration on 340B drug discount program.","Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE",,250000,0,0,2012-10-17T16:56:10.853000-04:00
1304526,1c43a02c-4519-4189-a2fe-68e475054d9d,Q3,POLICY ADVOCATES,72018,GLAXOSMITHKLINE,2012,third_quarter,PHA,"PDUFA
Medicare Part D","HOUSE OF REPRESENTATIVES,SENATE",22500,,0,0,2012-10-17T18:13:47.537000-04:00
1304637,a6f661e2-9c25-4731-bcf3-7e6677626fca,Q3,NEW JERSEY HOSPITAL ASSOCIATION,29128,NEW JERSEY HOSPITAL ASSOCIATION,2012,third_quarter,PHA,"Support provisions included in S. 3187, the Food and Drug Administration Safety and Innovation Act, which would help speed safe and effective medical products to patients and maintain our nations role as a leader in biomedical innovation. This legislation will drive timely review of new innovator drugs and medical devices, enhance the safety of the drug supply chain in an increasingly globalized market, increase incentives for the development of new antibiotics, renew mechanisms to ensure that childrens medicines are appropriately tested and labeled, and expedite the development and review of certain drugs for the treatment of serious or life-threatening diseases and conditions.","HOUSE OF REPRESENTATIVES,SENATE",,70000,0,0,2012-10-17T21:10:40.550000-04:00
1304708,bbe1ec07-0708-410b-b483-6ca3e60d77dd,Q3,POLICY ADVOCATES,72018,PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA,2012,third_quarter,PHA,"Prescription Drug User Fee Act (PDUFA)
Drug Importation","HOUSE OF REPRESENTATIVES,SENATE",,,0,0,2012-10-17T23:25:20.530000-04:00
1304709,aa1aa6d1-014d-446a-bbc7-16229dbd8b1d,Q3,THORN RUN PARTNERS,400534596,LONG TERM CARE PHARMACY ALLIANCE,2012,third_quarter,PHA,"S.1560, Nursing Home Resident Pain Relief Act of 2011; issues related to the implementation of the Affordable Care Act (ACA), DEA enforcement of controlled substances in nursing homes and the practice of consultant pharmacy; issues related to PDUFA including Senate amendment on hydrocodone abuse; H.R.4215, Medicare Pharmacy Transparency and Fair Auditing Act.","HOUSE OF REPRESENTATIVES,SENATE",50000,,0,0,2012-10-17T23:25:21.187000-04:00
1305555,aac4dd7a-3556-461c-a652-c160ef240072,Q3,FAEGRE BAKER DANIELS CONSULTING,34158,ALLIANCE FOR SAFE ONLINE PHARMACIES (ASOP),2012,third_quarter,PHA,Online pharmacies - S. 2002 and HR 4095,"Executive Office of the President (EOP),HOUSE OF REPRESENTATIVES,SENATE",,,0,0,2012-10-18T11:10:34.060000-04:00
1305697,49031758-2b8c-4b13-990a-5c20ae296af7,Q3,CAPITOLOGIC LLC,400426045,"BULALAW, LLC",2012,third_quarter,PHA,Federal funding of illegal prescription drug market interventions,"Drug Enforcement Administration (DEA),HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),Natl Institute of Justice,Office of Justice Program,SENATE",,,0,0,2012-10-18T11:25:25.543000-04:00
1305701,65fbf336-5c9b-4fb7-a72c-300261cc38fc,Q3,RICCHETTI INCORPORATED,62778,ELI LILLY AND COMPANY,2012,third_quarter,PHA,"Issues related to pediatric exclusivity policy;
Issues related to PDUFA reauthorization.","HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2012-10-18T11:25:53.150000-04:00
1305905,8beb599c-d6ab-4c10-9a51-63002aad5c6f,Q3,RICCHETTI INCORPORATED,62778,SANOFI-AVENTIS U S INC,2012,third_quarter,PHA,Issues related to PDUFA reauthorization.,"HOUSE OF REPRESENTATIVES,SENATE,U.S. Trade Representative (USTR)",30000,,0,0,2012-10-18T11:56:05.127000-04:00
1306052,7f956e1b-9b32-4d01-959b-567ae20a0309,Q3,AMERICAN VETERINARY MEDICAL ASSOCIATION,3630,AMERICAN VETERINARY MEDICAL ASSOCIATION,2012,third_quarter,PHA,"H.R. 965/S. 1211 Preservation of Antibiotics for Medical Treatment Act
H.R. 1406 Fairness to Pet Owmers Act
DEA regulations impending practice of veterinary medicine; seeking legislative change to underlying statute","Agriculture, Dept of (USDA),Defense, Dept of (DOD),Executive Office of the President (EOP),Federal Trade Commission (FTC),Government Accountability Office (GAO),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE",,140000,0,0,2012-10-18T12:32:32.133000-04:00
1306066,87d646ee-01e5-495b-9101-bc92e2b773dc,Q3,THE INGRAM GROUP LLC,400577737,PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA),2012,third_quarter,PHA,"Issues related to pharmaceutical importation and generic drug pricing, S.3187, and the FAIR Generics Act, S.1882.","HOUSE OF REPRESENTATIVES,SENATE",60000,,0,0,2012-10-18T12:34:37.490000-04:00
1306224,f8de7672-23c9-4864-b686-b584fadc5232,Q3,"GENENTECH, INC",15920,GENENTECH INC,2012,third_quarter,PHA,PHA: proposed cuts to Part B reimbursement. 340b reimbursement policy;,"HOUSE OF REPRESENTATIVES,SENATE",,1073000,0,0,2012-10-18T13:08:46.310000-04:00
1306309,5edee2be-f830-4f1f-aaae-b18a9eb3e51e,Q3,ELI LILLY AND COMPANY,13392,ELI LILLY AND COMPANY,2012,third_quarter,PHA,Hospital discounts (HR 3590),"Agriculture, Dept of (USDA),Commerce, Dept of (DOC),Food & Drug Administration (FDA),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),Office of Management & Budget (OMB),SENATE,State, Dept of (DOS),U.S. Trade Representative (USTR)",,3055000,0,0,2012-10-18T13:34:52.153000-04:00
1306335,718c1af6-f1c2-4c20-b9d2-cfbba3e438bc,Q3,HEALTHCARE DISTRIBUTION ALLIANCE(HDA)(FORMERLY HEALTHCARE DISTRIBUTION MANAGEMENT ASSOCIATION (HDMA),28776,HEALTHCARE DISTRIBUTION ALLIANCE (FORMERLY - HDMA),2012,third_quarter,PHA,Rx Pedigree (H.R. 3026/S. 3187); NASPER Reauthorization (H.R. 866); Prescription Drug Monitoring Programs (S. 2254/H.R. 4292/S.3187); Pill Mill Crackdown Act (H.R. 1065/S. 1760/S. 2297); Drug Abuse (S. 507); Drug Shortages (S. 296/ H.R. 2245/H.R. 3839/S. 3187/H.R. 5853/H.R. 5651); Cargo/Product Theft (S. 1002/H.R. 4223); Counterfeit Drugs (S. 1886/H.R. 3668/S. 3187),"Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",,222819,0,0,2012-10-18T13:41:00.287000-04:00
1306682,1d123d37-02e8-4560-b9b8-796b9f9b2574,Q3,KNIGHT CAPITOL CONSULTANTS,40036301,GENZYME CORPORATION,2012,third_quarter,PHA,"S. 606, Creating Hope Act of 2011, S. 296/H.R. 2245, Preserving Access to Life-Saving Medications Act, The Food and Drug Administration Safety and Innovation Act (PL 112-144) and amendments considered, including the Faster Access to Specialized Treatments Act (H.R. 4132) and the Transforming the Regulatory Environment to Accelerate Access to
Treatment (TREAT) Act (S. 2113).  Assess potential impact of sequestration on public health/food and drug programs.","HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2012-10-18T15:02:14.800000-04:00
1307540,5d5a5a32-ce1c-455f-aba4-aef77b5b280b,Q3,BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ,5153,THE MEDICINES COMPANY,2012,third_quarter,PHA,Regulatory and Reimbursement,,90000,,0,0,2012-10-18T16:41:49.400000-04:00
1307544,77a6d4e2-c34c-49c3-a8d0-6e03afac7430,Q3,"MARTIN & SEIBERT, L.C.",400970784,EXPRESS SCRIPTS,2012,third_quarter,PHA,General education and discussion relating to the tracking of drugs,SENATE,20000,,0,0,2012-10-18T16:41:50.883000-04:00
1307702,8629037f-3a54-4daf-a958-92c7675ff09b,Q3,CVS HEALTH (AND SUBSIDIARIES),302778,CVS CAREMARK INC,2012,third_quarter,PHA,"Issues related to prescription drug abuse, drug supply chain safety and prescriber education.
HR 2119  Ryan Creedon Act of 2011","HOUSE OF REPRESENTATIVES,SENATE,White House Office",,2320000,0,0,2012-10-18T17:05:58.183000-04:00
1307707,c450f42e-f91b-4283-8934-011a1e9bb2bb,Q3,AMERICAN PHARMACISTS ASSOCIATION,3071,AMERICAN PHARMACISTS ASSOCIATION,2012,third_quarter,PHA,"HCR(PL 111-152/111-148) concerning Medicare PartD;MTM;DME;center for medicare and medicaid innovation;transitions of care;pharmacy reimbursement;agency issues concerning risk evaluation mitigation strategies;PDUFA;prescription drug monitoring program,drug abuse,safe drug supply chain;standardized medication action plans;ACOs;pharmacists role in CMS innovation center initiatives;personalized medication lists; standardized pharmacy notice;immunization;HIT; compounding;medicare part B;SGR;DEA","Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Drug Enforcement Administration (DEA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Office of Natl Drug Control Policy (NDCP),SENATE",,,0,0,2012-10-18T17:06:00.183000-04:00
1308066,37edd923-024f-404a-8e95-19f48b88fd94,Q3,"BLUESTONE STRATEGIES, LLC",400658980,PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA),2012,third_quarter,PHA,Pharmacy Act; Drug Reimportation; Generic Brand Settlement; Generic Dispensing; Generic Biologics; and Specialty Drug Issues.,"HOUSE OF REPRESENTATIVES,SENATE",50000,,0,0,2012-10-18T18:17:57.800000-04:00
1308434,2d765f65-794d-40fe-83fc-7b7e5c2205d8,Q3,VAN SCOYOC ASSOCIATES,39837,UNIVERSITY OF CONNECTICUT,2012,third_quarter,PHA,"Issues related to FDA salaries and expenses; and extramural research:
   S.2375/H.R.5973, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 
   FY2013
   Public Law 112-55, Consolidated and Further Continuing Appropriations Act, FY2012","Commerce, Dept of (DOC),HOUSE OF REPRESENTATIVES,SENATE",40000,,0,0,2012-10-19T07:31:35.513000-04:00
1308442,6b3e59cb-6b49-4ff3-a744-5cccbba7d141,Q3,VAN SCOYOC ASSOCIATES,39837,UNIVERSITY OF MARYLAND BALTIMORE,2012,third_quarter,PHA,"S.2375/H.R.5973, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, FY2013, FDA initiatives; and Critical Path initiative.
S.3187/H.R.5651, Food and Drug Administration Safety and Innovation Act, FDA initiatives; Critical Path issues.","HOUSE OF REPRESENTATIVES,Natl Aeronautics & Space Administration (NASA),SENATE",30000,,0,0,2012-10-19T07:31:36.967000-04:00
1308447,cccd1cae-30fb-4838-b2ca-6a5b86b37b57,Q3,VAN SCOYOC ASSOCIATES,39837,UNIVERSITY OF PENNSYLVANIA SCHOOL OF MEDICINE,2012,third_quarter,PHA,"FDA funding initiatives; Critical Path Partnership.
  S.2375/H.R.5973, Agriculture,Rural Development,Food and Drug Administration,and Related Agencies Appropriations Act, FY2013
  Public Law 112-10, Department of Defense and Full-Year Continuing Appropriations Act, FY2011
  Public Law 112-55, Consolidated and Further Continuing Appropriations Act, FY2012 Monitor Prescription Drug User Fee Act (PDUFA)",SENATE,40000,,0,0,2012-10-19T07:32:38.310000-04:00
1308938,39986e36-10d7-4a76-846f-264198d62fa5,Q3,"GOVBIZ ADVANTAGE, INC.",294234,CATALYST HEALTH SOLUTIONS (CATAMARANRX),2012,third_quarter,PHA,Pharmacy Benefit Issues in health legislation;  PBM issues; General company congressional relations; business issues; oversight of PBMs,"HOUSE OF REPRESENTATIVES,SENATE",50000,,0,0,2012-10-19T09:44:54.060000-04:00
1309117,d39236b2-0381-4273-b1c4-eac3b2da26a8,3T,JENCKES AND ASSOCIATES,20551,LEO PHARMA INC.,2012,third_quarter,PHA,"Engage FDA, CDC and Hill policy makers on behalf of the client to support regulatory and outreach efforts in the U.S.","HOUSE OF REPRESENTATIVES,SENATE",,,0,1,2012-10-19T10:07:15.487000-04:00
1309155,96b767c3-6c8a-4df0-a598-7ebaeed4f3a1,Q3,MR. LORENZ HART,323295,AMERICAN CONSERVATIVE UNION,2012,third_quarter,PHA,Regulation of pseudoephedrine,"HOUSE OF REPRESENTATIVES,SENATE",19500,,0,0,2012-10-19T10:09:30.093000-04:00
1309180,9e4fa2b1-c6ae-461e-a9c2-be0e81703341,Q3,UNIVERSITY OF CONNECTICUT,39382,UNIVERSITY OF CONNECTICUT,2012,third_quarter,PHA,"Issues related to FDA salaries and expenses; and extramural research:
     S.2375/H.R.5973, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 
          FY2013.
     Public Law 112-55, Consolidated and Further Continuing Appropriations Act, FY2012.","Commerce, Dept of (DOC),HOUSE OF REPRESENTATIVES,SENATE",,70000,0,0,2012-10-19T10:12:40.747000-04:00
1309224,781831fe-96a3-44a9-b348-4bbd265e2dba,Q3,AMERICAN ADVERTISING FEDERATION,1411,AMERICAN ADVERTISING FEDERATION,2012,third_quarter,PHA,"Proposals to limit or restrict direct-to-consumer advertising of pharmaceuticals
Proposals to require a moratorium on the advertising of new prescription medicines
Proposals to extend the Food and Drug Administration authority for the advertising of over-the-counter medications
HR 741 To amend the Federal Food, Drug and Cosmetic Act to prohibit the marketing of authorized generic drugs H.Res. 343 Disapproving the Supreme Courts decision in Sorrell v. IMS Health
Oppose proposals to add overly-burdensome product warnings to DTC advertising","Agriculture, Dept of (USDA),Centers For Disease Control & Prevention (CDC),Commerce, Dept of (DOC),Federal Communications Commission (FCC),Federal Trade Commission (FTC),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Natl Telecommunications & Information Administration (NTIA),SENATE",,20000,0,0,2012-10-19T10:14:53.850000-04:00
1309466,7d353ee0-4cd0-4419-96cc-121cb3813131,Q3,"THE OB-C GROUP, LLC",29802,ELI LILLY,2012,third_quarter,PHA,No specific bill number: matters relating to pharmaceutical manufacturers and Medicare Part D.,"HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2012-10-19T10:32:36.127000-04:00
1309595,11b5535d-3ff8-4727-8f6a-98ef5aa54967,Q3,"OMNICARE, INC.",321112,OMNICARE INC,2012,third_quarter,PHA,HR 4215:  Support legislation relating to standardized audit standards for pharmacies with Medicare drug benefit sponsors,"HOUSE OF REPRESENTATIVES,SENATE",,120000,0,0,2012-10-19T10:41:31.133000-04:00
1309606,a2c7d05f-bb55-42e3-9945-4ba5bed418fa,Q3,EMPIRE CONSULTING GROUP,400703105,PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA,2012,third_quarter,PHA,"""Dual eligibles"" (Medicare-Medicaid) issues; and Medicare Prescription Drug Act issues.",HOUSE OF REPRESENTATIVES,30000,,0,0,2012-10-19T10:42:36.727000-04:00
1309842,191bb4bf-1427-49ae-bdd1-83dc4e075044,Q3,"BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC",292972,BOEHRINGER INGELHEIM USA CORPORATION,2012,third_quarter,PHA,Drug Shortages; The Preserving Access to Life Saving Medicines Act (S. 296),"Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",,710000,0,0,2012-10-19T11:07:16.370000-04:00
1310174,a093a889-68db-4b0c-a81a-95086118cab5,Q3,HAAKE & ASSOCIATES,17226,JOHNSON & JOHNSON SERVICES INC.,2012,third_quarter,PHA,Policy and procurement matters related to vaccines,"Army, Dept of (Other),Defense, Dept of (DOD),Defense Logistics Agency,HOUSE OF REPRESENTATIVES,Navy, Dept of,SENATE,U.S. Marines",20000,,0,0,2012-10-19T11:35:38.273000-04:00
1310211,dadae4f8-6fbb-4446-a34f-e89f7b9fa3d5,Q3,BLUECROSS BLUESHIELD OF TENNESSEE,6440,BLUECROSS BLUESHIELD OF TENNESSEE,2012,third_quarter,PHA,General Pharmacy Issues,"HOUSE OF REPRESENTATIVES,SENATE",,40000,0,0,2012-10-19T11:37:54.097000-04:00
1310295,40873dd2-8a29-40cd-9a71-01069c73807e,Q3,ARNOLD & PORTER KAYE SCHOLER LLP,4301,INTERNATIONAL ACADEMY OF COMPOUNDING PHARMACISTS,2012,third_quarter,PHA,Issues related to the regulation of the practice of pharmacy compounding.,"HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2012-10-19T11:43:31.590000-04:00
1310832,0f2bddde-3853-46a2-800b-c527e88b8815,Q3,"VAN HEUVELEN STRATEGIES, LLC",321874,CVS HEALTH (FORMERLY KNOWN AS CVS CAREMARK),2012,third_quarter,PHA,"Issues related to prescription drug abuse, drug supply chain safety and prescriber education.
H.R.2119, Ryan Creedon Act of 2011","HOUSE OF REPRESENTATIVES,SENATE,White House Office",40000,,0,0,2012-10-19T12:41:58.710000-04:00
1310844,fccf8236-0be6-459a-a3d9-005cc4db26de,Q3,"RASKY PARTNERS, INC.",297410,ELI LILLY AND CO,2012,third_quarter,PHA,"Monitor biologics related issues, Medicare Part D","HOUSE OF REPRESENTATIVES,SENATE",22500,,0,0,2012-10-19T12:44:03.067000-04:00
1310955,d1c5718d-49ba-4501-a66b-20136de91374,Q3,"VAN HEUVELEN STRATEGIES, LLC",321874,DAVITA,2012,third_quarter,PHA,"Provisions pertaining to kidney care, dialysis, Medicare, Medicaid, CMS reimbursement issues, and health insurance.  Implementation of Patient Protection and Affordable Care Act. Implementation of the Budget Control Act.","HOUSE OF REPRESENTATIVES,SENATE",60000,,0,0,2012-10-19T12:58:48.470000-04:00
1311001,c1c55f8a-bdd5-4d44-ac98-0994b12da21d,Q3,COVIDIEN LP,319778,COVIDIEN LP,2012,third_quarter,PHA,"Issues involving controlled substance and pain and addiction drugs generally;  H.R. 2119: Ryan Creedon Act of 2011To amend the Controlled Substances Act to require practitioners to obtain particular training or special certification, approved by the Attorney General, on addiction to and abuse of controlled substances and appropriate and safe use of controlled substances in schedule II, III, IV, or V, and for other purposes; Issues related to acetaminophen.","Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE",,460000,0,0,2012-10-19T13:01:59.903000-04:00
1311087,5cb29314-4cb9-40a8-9d19-91c0a9efd2a0,Q3,MCDERMOTT WILL & SCHULTE LLP,24338,RURAL REFERRAL CENTER/SOLE COMMUNITY HOSPITAL COALITION,2012,third_quarter,PHA,Amendments to Section 340B of the Public Health Service Act to gain eligibility for rural referral centers and sole community hospitals in the federal discount drug purchasing program.,"Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE",130000,,0,0,2012-10-19T13:14:36.843000-04:00
1311368,d7631098-80b3-4d0f-a939-5b022999066d,Q3,AMERICAN OPTOMETRIC ASSOCIATION,2981,AMERICAN OPTOMETRIC ASSOCIATION,2012,third_quarter,PHA,"S 2297, A bill to amend the Controlled Substances Act to make any substance containing hydrocodone a schedule II drug, all sections relating to vision.","HOUSE OF REPRESENTATIVES,SENATE",,100000,0,0,2012-10-19T13:47:26.757000-04:00
1311396,64d25597-5d37-4057-a8f4-2fd1328132db,Q3,"AMERICA'S HEALTH INSURANCE PLANS, INC. (AHIP)",1581,AMERICA'S HEALTH INSURANCE PLANS INC (AHIP),2012,third_quarter,PHA,"H.R. 979, FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act (Lynch)  FEHBP prescription drugs 16.  Specific Lobbying Issues (continued):
H.R.1946, Preserving Hometown Independent Pharmacies Act (Marino)  antitrust exemption for independent pharmacies
H.R. 3995, Protecting Consumer Access to Generic Drugs Act (Rush)  pay-for-delay settlements
S. 27, Preserve Access to Affordable Generics Act (Kohl)  pay-for-delay settlements
S. 2002, Online Pharmacy Safety Act (Feinstein)  establishes standards for on-line pharmacies 
S. 2193, Ensuring Safe Medical Devices for Patients (Merkley)  FDA oversight of medical devices 
S. 3187, the FDA Safety and Innovation Act (Harkin)  pharmaceutical, medical device issues

Regulatory Issues:
Issues relating to long term safety and effectiveness of medical devices and drugs, including registries; issues relating to post-market surveillance of drugs and medical devices; issues relating to access for investigational drugs; and other issues relating to health care reform implementation.","Agency for Healthcare Research & Quality (AHRQ),Centers For Medicare and Medicaid Services (CMS),Executive Office of the President (EOP),Federal Bureau of Investigation (FBI),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Internal Revenue Service (IRS),Justice, Dept of (DOJ),Labor, Dept of (DOL),Medicare Payment Advisory Commission (MedPAC),Office of Management & Budget (OMB),Office of Personnel Management (OPM),Pension & Welfare Benefits Administration,SENATE,Treasury, Dept of,White House Office",,2630000,0,0,2012-10-19T13:49:38.160000-04:00
1311639,cd8032b6-ed4e-4017-a0d3-3bad5b7cc506,Q3,340B HEALTH,316434,340B HEALTH,2012,third_quarter,PHA,Discussing the importance of the 340B drug discount program and improving program oversight.  Advocating for extension of program to the inpatient setting and repeal of the orphan drug ban.,"HOUSE OF REPRESENTATIVES,Natl Economic Council (NEC),SENATE,White House Office",,235879,0,0,2012-10-19T14:14:17.473000-04:00
1311694,3b1df5bd-6552-4e40-9fcb-6d0c4067ac6c,Q3,"COMPASS CONSULTING GROUP, LLC",295031,"AMYLIN PHARMACEUTICALS, INC.",2012,third_quarter,PHA,"General FDA, pharmaceutical, and Medicare issues.","HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2012-10-19T14:17:41.313000-04:00
1312013,42d8feb6-58ca-4378-a432-342d35b43475,Q3,NATIONAL RURAL HEALTH ASSOCATION,53048,NATIONAL RURAL HEALTH ASSOCATION,2012,third_quarter,PHA,Support for 340B drug program.,"Centers For Medicare and Medicaid Services (CMS),Federal Communications Commission (FCC),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE",,25222,0,0,2012-10-19T14:35:49.997000-04:00